中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
11期
8-10
,共3页
胡萌%赵小强%朱冰柯%张艳芝%黄彩娟%杨海平
鬍萌%趙小彊%硃冰柯%張豔芝%黃綵娟%楊海平
호맹%조소강%주빙가%장염지%황채연%양해평
环磷酰胺%依托泊苷%抗胸腺细胞球蛋白%系统性红斑狼疮
環燐酰胺%依託泊苷%抗胸腺細胞毬蛋白%繫統性紅斑狼瘡
배린선알%의탁박감%항흉선세포구단백%계통성홍반랑창
Cyclophosphamide%Etoposide%Anti-thymocyte globulin%Systemic lupus eythematosus
目的:研究短疗程大剂量环磷酰胺和依托泊苷、体内去T细胞预处理方案自体移植治疗系统性红斑狼疮的疗效及安全性。方法:入组患者采髓后体外低温保存,预处理方案:环磷酰胺60 mg/kg,依托泊苷10~20 mg/kg,均于移植前的第1、2天应用;骨髓输注后第2~6天应用抗胸腺细胞球蛋白(ATG)3~5 mg/(kg·d)。结果:所有患者均成功实现了造血重建;患者白细胞重建时间8~14 d,中位时间11 d;血小板重建时间12~36 d,中位时间18 d;移植后原有肝肾功能损害逐渐改善,未发生移植相关死亡;移植前后狼疮活动指数、血沉、补体、抗核抗体比较差异有统计学意义(P<0.05)。结论:应用该方案进行自体移植,安全性好,疗效肯定,适合基层医院开展。
目的:研究短療程大劑量環燐酰胺和依託泊苷、體內去T細胞預處理方案自體移植治療繫統性紅斑狼瘡的療效及安全性。方法:入組患者採髓後體外低溫保存,預處理方案:環燐酰胺60 mg/kg,依託泊苷10~20 mg/kg,均于移植前的第1、2天應用;骨髓輸註後第2~6天應用抗胸腺細胞毬蛋白(ATG)3~5 mg/(kg·d)。結果:所有患者均成功實現瞭造血重建;患者白細胞重建時間8~14 d,中位時間11 d;血小闆重建時間12~36 d,中位時間18 d;移植後原有肝腎功能損害逐漸改善,未髮生移植相關死亡;移植前後狼瘡活動指數、血沉、補體、抗覈抗體比較差異有統計學意義(P<0.05)。結論:應用該方案進行自體移植,安全性好,療效肯定,適閤基層醫院開展。
목적:연구단료정대제량배린선알화의탁박감、체내거T세포예처리방안자체이식치료계통성홍반랑창적료효급안전성。방법:입조환자채수후체외저온보존,예처리방안:배린선알60 mg/kg,의탁박감10~20 mg/kg,균우이식전적제1、2천응용;골수수주후제2~6천응용항흉선세포구단백(ATG)3~5 mg/(kg·d)。결과:소유환자균성공실현료조혈중건;환자백세포중건시간8~14 d,중위시간11 d;혈소판중건시간12~36 d,중위시간18 d;이식후원유간신공능손해축점개선,미발생이식상관사망;이식전후랑창활동지수、혈침、보체、항핵항체비교차이유통계학의의(P<0.05)。결론:응용해방안진행자체이식,안전성호,료효긍정,괄합기층의원개전。
Objective:To study the efficacy and safety of pretreatment regimen of high doses CTX and VP-16 combined with vivo T cell removal in autologous transplantation of Systemic Lupus Erythematosus(SLE). Method:After autologous bone marrow collection,the pretreatment regimen was given. The regimen included cyclophosphamide 60 mg/kg, etoposide 10-20 mg/kg,on the first day and the second day before the transplantation,antithymocyte globulin(ATG) 3-5 mg/(kg·d),from the second day to the sixth day after bone marrow infusion. Result:All patients successfully achieved hematopoietic reconstruction,the median time of white cells recovered was 11(8-14 )d,the median time of platelets recovered is 18(12-36)d,no transplant-related death occur;when the lupus activity index,ESR, complement and antinuclear antibodies were compared before and after transplantation,the difference were statistically significant(P<0.05). Conclusion:The application of this regimen have good safety,significant treatment effects,is suitable for primary hospitals.